| Systematic (IUPAC) name | |
|---|---|
| 4-[(2-chlorobenzyl)oxy]-1-methyl-1H-imidazo[4,5-c]pyridine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Routes | ? |
| Identifiers | |
| CAS number | 87034-87-5 |
| ATC code | None |
| PubChem | CID 3086242 |
| ChemSpider | 2342913 |
| UNII | GX1Q848LV4 |
| Chemical data | |
| Formula | C14H12ClN3O |
| Mol. mass | 273.72 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Bamaluzole is a GABA receptor agonist.[1] It was patented as an anticonvulsant by Merck but was never marketed.[1] There is no known scientific literature on bamaluzole and little else is known about it.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)